Since the start of the COVID-19 pandemic, we have learned how it affects certain patient populations and how it can cause headaches such as arrhythmias.
In a study published in JAMA in February, 44.4% of patients evaluated in Wuhan, China, were treated in intensive care sets due to arrhythmia-like headaches.Arrhythmias would possibly also be bothered by severe systemic inflammatory situations relevant to COVID-19.
The pandemic has also affected arrhythmia control, with an impact on telehealth.
“The pandemic and the desire to provide remote medical care have overburdened the implementation of these technologies,” Jonathan P said.Piccini, MD, MHS, FHRS, Associate Professor of Medicine and Director of Cardiac Electrophysiology at Duke University Medical Center, Healio.”For example, at our [electrophysiological] clinic in Duke, before the pandemic, telehealth visits accounted for less than 5% of visits.Two weeks after the start of COVID, more than 90% of our clinic visits were telehealth meetings..»
Despite the benefits of teleaptitude, such as reducing face-to-face contact, considerations remain as to whether generation is sufficient to fill the vacuum created by minimizing the number of face-to-face visits to the pandemic.has been triggered since the pandemic, so many cardiologists are grateful to offer them a tool to provide ongoing care for serious chronic medical conditions It is vital to note that telefitness does not update the need for all physical care in person, adding a workplace visit and essential medical procedures.
“While the use of virtual visits has helped us partially fill the void, many cardiologists are involved [that delayed care] would possibly lead to an uncontrolled progression of disease for some patients,” J.Cantillon, MD, FACC, FHRS, medical staff and associate chief of the electrophysiology and cardiac stimulation segment at the Department of Cardiovascular Medicine Robert and Suzanne Tomich of Sydell and Arnold Tom Vascular
Patients with COVID-19 may have arrhythmias. In addition, because medications such as hydroxychloroquine can increase the threat of severe central rhythm abnormalities, increasing QT interval elongation, ventricular tachycardia, traumatic ventricular inflammation or death.This led to FDA protection, alert in April, warn fitness professionals and patients about the use of hydroxychloroquine outdoors in hospitals or clinical trials.
Piccini told Healio that his establishment had not used a significant amount of hydroxychloroquine to treat COVID-19, as the maximum number of patients enrolled in clinical trials with other experimental drugs. In the early stages of the pandemic, Piccini and his colleagues developed practice algorithms for ECG and corrected follow-up of the QT period for hydroxychloroquine.
“Fortunately, we are aware of any drug-related ventricular arrhythmia in our health care formula due to the effective use of centralized off-site surveillance for hospitalized patients, among other protective measures,” Cantillon said.
In a study paper published in the Journal of the American College of Cardiology, cellular outpatient heart telemetry advanced arrhythmia monitoring and corrected the QT period in COVID-19 patients who were treated with hydroxychloroquine or azithromycin.
“Several centers across the country have used this approach,” Piccini said.”This will be a lasting effect of COVID: the increased use of outpatient follow-up for electrocardiogram protection assessments.There are many unanswered questions and we still have a lot to learn.”
Outpatient telemetry tracking for patients with arrhythmias is not a new approach; in the past it was used to evaluate the patient’s reaction to a new antiarrhythmic drug and possible effects outside the target.
Although we know more about the effects of hydroxychloroquine in patients with arrhythmias, it turns out that the drug probably has no role to play in the COVID-19 remedy.
“There is no random knowledge about the continued use of hydroxychloroquine,” Piccini said.”While there was some initial evidence that this might be helpful, the following knowledge of randomized clinical trials showed no advantages or threats of prospective arrhythmia.”
Cantillon said: “Ultimately, only well-conducted randomized clinical trials will reveal the most promising remedies and allow us to further quantify, as it should be, the benefit / risk ratio of a given therapy.
The American Heart Association has developed a registry to organize and collect knowledge, studies and remedy protocols for COVID-19, in addition to threat points to related adverse CV outcomes.The registration, which works through its Get With the Guidelines program, will be available at more than 2,400 hospitals.
“This record allows us to organize and percentage valuable knowledge between centers that can then be interviewed to obtain data on the disease, sum the frequency of arrhythmias and any express arrangements with the underlying situations and/or check results, for example,” Cantillon said.
In the era of COVID-19, multidisciplinary collaboration requires well-organized ways of care and communication between teams.
“This is not fundamentally different from pre-pandemic collaboration, because of sufficiently intense considerations and perhaps because of a small margin of error,” Cantillon said.
Even with one approach, cardiologists and physical health professionals are encouraged through the opportunity to work with experts in other fields to treat those patients.
“Multidisciplinary collaboration in the COVID-19 era is a beauty,” Piccini said.”In our fitness care formula and fitness formulas across the country, doctors from various specialties are encouraged through the challenge and run in combination with more of The Pandemic has also led to many inventions through collaboration.It has been very rewarding to work with our colleagues in internal medicine, anesthesiology, infectious diseases and surgery to better perceive how we can provide more effective, coordinated and effective care in changing circumstances..
Daniel J.Cantillon, MD, FACC, FHRS, can be contacted at [email protected]; Twitter: @djcantillonmd.
Jonathan P. Piccini, MD, MHS, FHRS, can be reached at [email protected]; Twitter: @jonpiccinisr.
Get the newest news and delivered to your inbox
© 2020 Healio All rights reserved.
Receive the latest news and in your inbox
© 2020 Healio All rights reserved.